APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Vascular Stent

Non-vascular stents are specialized medical devices used for relieving the strictures in gastrointestinal tract, ureteral tract and airway tracts. These are also used for holding open the narrowed lumens during complex surgical procedure to allow free flow of body fluids. On the basis of its applications there are three different types of non-vascular stents are available: pulmonology stents, urology stents, and gastroenterology stents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Non-vascular stents are specialized medical devices used for relieving the strictures in gastrointestinal tract, ureteral tract and airway tracts. These are also used for holding open the narrowed lumens during complex surgical procedure to allow free flow of body fluids. On the basis of its applications there are three different types of non-vascular stents are available: pulmonology stents, urology stents, and gastroenterology stents.

Selected research

Market Outlook & Growth Opportunities

Global Non Vascular Stent Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchNon Vascular Stent Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Vascular Stent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Non Vascular Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Vascular Stent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Vascular Stent Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Non-vascular stents are specialized medical devices used for relieving the strictures in gastrointestinal tract, ureteral tract and airway tracts. These are also used for holding open the narrowed lumens during complex surgical procedure to allow free flow of body fluids. On the basis of its applications there are three different types of non-vascular stents are available: pulmonology stents, urology stents, and gastroenterology stents.

In the Asia Pacific market, the leading manufacturers of non-vascular stents are Boston Scientific, C.R. Bard, Cook Medical, Olympus, B. Braun, Medtronic, M.I.Tech, Taewoong Medical, Merit Medical and ConMed.

This report provides an overview of the global Non Vascular Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Non Vascular Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non Vascular Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non Vascular Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Non Vascular Stent Segment by Company

Boston Scientific

C.R. Bard

Cook Medical

Olympus

B. Braun

Medtronic

M.I.Tech

Taewoong Medical

Merit Medical

ConMed

Applied Medical

Ella-CS

Garson

Micro-Tech

S&G Biotech

Non Vascular Stent Segment by Type

Gastrointestinal Stents

Pulmonary (Airway) Stents

Urological Stents

Non Vascular Stent Segment by Application

Hospital

Clinic

Non Vascular Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non Vascular Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non Vascular Stent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non Vascular Stent significant trends, drivers, influence factors in global and regions.

6. To analyze Non Vascular Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Vascular Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Vascular Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Vascular Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non Vascular Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non Vascular Stent industry.

Chapter 3: Detailed analysis of Non Vascular Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non Vascular Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non Vascular Stent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non Vascular Stent Industry Trends Table 2. Non Vascular Stent Industry Drivers Table 3. Non Vascular Stent Industry Opportunities and Challenges Table 4. Non Vascular Stent Industry Restraints Table 5. Global Non Vascular Stent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non Vascular Stent Revenue Share by Company (2021-2026) Table 7. Global Non Vascular Stent Sales Volume by Company (units) & (2021-2026) Table 8. Global Non Vascular Stent Sales Volume Share by Company (2021-2026) Table 9. Global Non Vascular Stent Average Price (USD/unit) of Company (2021-2026) Table 10. Global Non Vascular Stent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non Vascular Stent Key Company Manufacturing Base & Headquarters Table 12. Global Non Vascular Stent Company, Product Type & Application Table 13. Global Non Vascular Stent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non Vascular Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gastrointestinal Stents Table 18. Significant Companies of Pulmonary (Airway) Stents Table 19. Significant Companies of Urological Stents Table 20. Global Non Vascular Stent Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Non Vascular Stent Sales Volume by Type (2021-2026) & (units) Table 22. Global Non Vascular Stent Sales Volume by Type (2027-2032) & (units) Table 23. Global Non Vascular Stent Sales Volume Share by Type (2021-2026) Table 24. Global Non Vascular Stent Sales Volume Share by Type (2027-2032) Table 25. Global Non Vascular Stent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non Vascular Stent Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Non Vascular Stent Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Non Vascular Stent Sales Value Share by Type (2021-2026) Table 29. Global Non Vascular Stent Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Global Non Vascular Stent Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 33. Global Non Vascular Stent Sales Volume by Application (2021-2026) & (units) Table 34. Global Non Vascular Stent Sales Volume by Application (2027-2032) & (units) Table 35. Global Non Vascular Stent Sales Volume Share by Application (2021-2026) Table 36. Global Non Vascular Stent Sales Volume Share by Application (2027-2032) Table 37. Global Non Vascular Stent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Non Vascular Stent Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Non Vascular Stent Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Non Vascular Stent Sales Value Share by Application (2021-2026) Table 41. Global Non Vascular Stent Sales Value Share by Application (2027-2032) Table 42. Global Non Vascular Stent Sales by Region: 2021 VS 2025 VS 2032 (units) Table 43. Global Non Vascular Stent Sales by Region (2021-2026) & (units) Table 44. Global Non Vascular Stent Sales Market Share by Region (2021-2026) Table 45. Global Non Vascular Stent Sales by Region (2027-2032) & (units) Table 46. Global Non Vascular Stent Sales Market Share by Region (2027-2032) Table 47. Global Non Vascular Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Non Vascular Stent Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Non Vascular Stent Sales Value Share by Region (2021-2026) Table 50. Global Non Vascular Stent Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Non Vascular Stent Sales Value Share by Region (2027-2032) Table 52. Global Non Vascular Stent Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Non Vascular Stent Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Non Vascular Stent Sales by Country: 2021 VS 2025 VS 2032 (units) Table 55. Global Non Vascular Stent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Non Vascular Stent Sales by Country (2021-2026) & (units) Table 57. Global Non Vascular Stent Sales Market Share by Country (2021-2026) Table 58. Global Non Vascular Stent Sales by Country (2027-2032) & (units) Table 59. Global Non Vascular Stent Sales Market Share by Country (2027-2032) Table 60. Global Non Vascular Stent Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Non Vascular Stent Sales Value Market Share by Country (2021-2026) Table 62. Global Non Vascular Stent Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Non Vascular Stent Sales Value Market Share by Country (2027-2032) Table 64. Boston Scientific Company Information Table 65. Boston Scientific Business Overview Table 66. Boston Scientific Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Boston Scientific Non Vascular Stent Product Portfolio Table 68. Boston Scientific Recent Development Table 69. C.R. Bard Company Information Table 70. C.R. Bard Business Overview Table 71. C.R. Bard Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. C.R. Bard Non Vascular Stent Product Portfolio Table 73. C.R. Bard Recent Development Table 74. Cook Medical Company Information Table 75. Cook Medical Business Overview Table 76. Cook Medical Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Cook Medical Non Vascular Stent Product Portfolio Table 78. Cook Medical Recent Development Table 79. Olympus Company Information Table 80. Olympus Business Overview Table 81. Olympus Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Olympus Non Vascular Stent Product Portfolio Table 83. Olympus Recent Development Table 84. B. Braun Company Information Table 85. B. Braun Business Overview Table 86. B. Braun Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. B. Braun Non Vascular Stent Product Portfolio Table 88. B. Braun Recent Development Table 89. Medtronic Company Information Table 90. Medtronic Business Overview Table 91. Medtronic Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Medtronic Non Vascular Stent Product Portfolio Table 93. Medtronic Recent Development Table 94. M.I.Tech Company Information Table 95. M.I.Tech Business Overview Table 96. M.I.Tech Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. M.I.Tech Non Vascular Stent Product Portfolio Table 98. M.I.Tech Recent Development Table 99. Taewoong Medical Company Information Table 100. Taewoong Medical Business Overview Table 101. Taewoong Medical Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Taewoong Medical Non Vascular Stent Product Portfolio Table 103. Taewoong Medical Recent Development Table 104. Merit Medical Company Information Table 105. Merit Medical Business Overview Table 106. Merit Medical Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Merit Medical Non Vascular Stent Product Portfolio Table 108. Merit Medical Recent Development Table 109. ConMed Company Information Table 110. ConMed Business Overview Table 111. ConMed Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. ConMed Non Vascular Stent Product Portfolio Table 113. ConMed Recent Development Table 114. Applied Medical Company Information Table 115. Applied Medical Business Overview Table 116. Applied Medical Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Applied Medical Non Vascular Stent Product Portfolio Table 118. Applied Medical Recent Development Table 119. Ella-CS Company Information Table 120. Ella-CS Business Overview Table 121. Ella-CS Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Ella-CS Non Vascular Stent Product Portfolio Table 123. Ella-CS Recent Development Table 124. Garson Company Information Table 125. Garson Business Overview Table 126. Garson Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Garson Non Vascular Stent Product Portfolio Table 128. Garson Recent Development Table 129. Micro-Tech Company Information Table 130. Micro-Tech Business Overview Table 131. Micro-Tech Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Micro-Tech Non Vascular Stent Product Portfolio Table 133. Micro-Tech Recent Development Table 134. S&G Biotech Company Information Table 135. S&G Biotech Business Overview Table 136. S&G Biotech Non Vascular Stent Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. S&G Biotech Non Vascular Stent Product Portfolio Table 138. S&G Biotech Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Non Vascular Stent Distributors List Table 142. Non Vascular Stent Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Non Vascular Stent Product Image Figure 2. Global Non Vascular Stent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non Vascular Stent Sales (2021-2032) & (units) Figure 5. Global Non Vascular Stent Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Non Vascular Stent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gastrointestinal Stents Image Figure 10. Pulmonary (Airway) Stents Image Figure 11. Urological Stents Image Figure 12. Global Non Vascular Stent Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Non Vascular Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Non Vascular Stent Sales Volume Share by Type (2021-2032) Figure 15. Global Non Vascular Stent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Non Vascular Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Non Vascular Stent Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Non Vascular Stent Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 21. Global Non Vascular Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Non Vascular Stent Sales Volume Share by Application (2021-2032) Figure 23. Global Non Vascular Stent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Non Vascular Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Non Vascular Stent Sales Value Share by Application (2021-2032) Figure 26. Global Non Vascular Stent Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 27. Global Non Vascular Stent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Non Vascular Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Non Vascular Stent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 31. North America Non Vascular Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Non Vascular Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Non Vascular Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 37. South America Non Vascular Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Non Vascular Stent Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Non Vascular Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Non Vascular Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Non Vascular Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Non Vascular Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Non Vascular Stent Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Non Vascular Stent Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Gastrointestinal Stents
  • Pulmonary (Airway) Stents
  • Urological Stents
Applications
  • Hospital
  • Clinic
Companies covered
  • Boston Scientific
  • C.R. Bard
  • Cook Medical
  • Olympus
  • B. Braun
  • Medtronic
  • M.I.Tech
  • Taewoong Medical
  • Merit Medical
  • ConMed
  • Applied Medical
  • Ella-CS
  • Garson
  • Micro-Tech
  • S&G Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non Vascular Stent Sales Value (2021-2032)
  4. 1.2.2 Global Non Vascular Stent Sales Volume (2021-2032)
  5. 1.2.3 Global Non Vascular Stent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non Vascular Stent Market Dynamics
  1. 2.1 Non Vascular Stent Industry Trends
  2. 2.2 Non Vascular Stent Industry Drivers
  3. 2.3 Non Vascular Stent Industry Opportunities and Challenges
  4. 2.4 Non Vascular Stent Industry Restraints
3 Non Vascular Stent Market by Company
  1. 3.1 Global Non Vascular Stent Company Revenue Ranking in 2025
  2. 3.2 Global Non Vascular Stent Revenue by Company (2021-2026)
  3. 3.3 Global Non Vascular Stent Sales Volume by Company (2021-2026)
  4. 3.4 Global Non Vascular Stent Average Price by Company (2021-2026)
  5. 3.5 Global Non Vascular Stent Company Ranking (2024-2026)
  6. 3.6 Global Non Vascular Stent Company Manufacturing Base and Headquarters
  7. 3.7 Global Non Vascular Stent Company Product Type and Application
  8. 3.8 Global Non Vascular Stent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non Vascular Stent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non Vascular Stent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non Vascular Stent Market by Type
  1. 4.1 Non Vascular Stent Type Introduction
  2. 4.1.1 Gastrointestinal Stents
  3. 4.1.2 Pulmonary (Airway) Stents
  4. 4.1.3 Urological Stents
  5. 4.2 Global Non Vascular Stent Sales Volume by Type
  6. 4.2.1 Global Non Vascular Stent Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non Vascular Stent Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Non Vascular Stent Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Non Vascular Stent Sales Value by Type
  10. 4.3.1 Global Non Vascular Stent Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non Vascular Stent Sales Value by Type (2021-2032)
  12. 4.3.3 Global Non Vascular Stent Sales Value Share by Type (2021-2032)
5 Non Vascular Stent Market by Application
  1. 5.1 Non Vascular Stent Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Non Vascular Stent Sales Volume by Application
  5. 5.2.1 Global Non Vascular Stent Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non Vascular Stent Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non Vascular Stent Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non Vascular Stent Sales Value by Application
  9. 5.3.1 Global Non Vascular Stent Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non Vascular Stent Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non Vascular Stent Sales Value Share by Application (2021-2032)
6 Non Vascular Stent Regional Sales and Value Analysis
  1. 6.1 Global Non Vascular Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non Vascular Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Non Vascular Stent Sales by Region: 2021-2026
  4. 6.2.2 Global Non Vascular Stent Sales by Region (2027-2032)
  5. 6.3 Global Non Vascular Stent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non Vascular Stent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non Vascular Stent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non Vascular Stent Sales Value by Region (2027-2032)
  9. 6.5 Global Non Vascular Stent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non Vascular Stent Sales Value (2021-2032)
  12. 6.6.2 North America Non Vascular Stent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non Vascular Stent Sales Value (2021-2032)
  15. 6.7.2 Europe Non Vascular Stent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non Vascular Stent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non Vascular Stent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non Vascular Stent Sales Value (2021-2032)
  21. 6.9.2 South America Non Vascular Stent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non Vascular Stent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non Vascular Stent Sales Value Share by Country, 2025 VS 2032
7 Non Vascular Stent Country-level Sales and Value Analysis
  1. 7.1 Global Non Vascular Stent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non Vascular Stent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non Vascular Stent Sales by Country (2021-2032)
  4. 7.3.1 Global Non Vascular Stent Sales by Country (2021-2026)
  5. 7.3.2 Global Non Vascular Stent Sales by Country (2027-2032)
  6. 7.4 Global Non Vascular Stent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non Vascular Stent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non Vascular Stent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non Vascular Stent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non Vascular Stent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non Vascular Stent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non Vascular Stent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non Vascular Stent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non Vascular Stent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non Vascular Stent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non Vascular Stent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non Vascular Stent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non Vascular Stent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non Vascular Stent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non Vascular Stent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non Vascular Stent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non Vascular Stent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non Vascular Stent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non Vascular Stent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non Vascular Stent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non Vascular Stent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non Vascular Stent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non Vascular Stent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non Vascular Stent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non Vascular Stent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non Vascular Stent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non Vascular Stent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non Vascular Stent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non Vascular Stent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non Vascular Stent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non Vascular Stent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non Vascular Stent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non Vascular Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific
  2. 8.1.1 Boston Scientific Company Information
  3. 8.1.2 Boston Scientific Business Overview
  4. 8.1.3 Boston Scientific Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Non Vascular Stent Product Portfolio
  6. 8.1.5 Boston Scientific Recent Developments
  7. 8.2 C.R. Bard
  8. 8.2.1 C.R. Bard Company Information
  9. 8.2.2 C.R. Bard Business Overview
  10. 8.2.3 C.R. Bard Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 C.R. Bard Non Vascular Stent Product Portfolio
  12. 8.2.5 C.R. Bard Recent Developments
  13. 8.3 Cook Medical
  14. 8.3.1 Cook Medical Company Information
  15. 8.3.2 Cook Medical Business Overview
  16. 8.3.3 Cook Medical Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cook Medical Non Vascular Stent Product Portfolio
  18. 8.3.5 Cook Medical Recent Developments
  19. 8.4 Olympus
  20. 8.4.1 Olympus Company Information
  21. 8.4.2 Olympus Business Overview
  22. 8.4.3 Olympus Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Olympus Non Vascular Stent Product Portfolio
  24. 8.4.5 Olympus Recent Developments
  25. 8.5 B. Braun
  26. 8.5.1 B. Braun Company Information
  27. 8.5.2 B. Braun Business Overview
  28. 8.5.3 B. Braun Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Non Vascular Stent Product Portfolio
  30. 8.5.5 B. Braun Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Non Vascular Stent Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 M.I.Tech
  38. 8.7.1 M.I.Tech Company Information
  39. 8.7.2 M.I.Tech Business Overview
  40. 8.7.3 M.I.Tech Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 M.I.Tech Non Vascular Stent Product Portfolio
  42. 8.7.5 M.I.Tech Recent Developments
  43. 8.8 Taewoong Medical
  44. 8.8.1 Taewoong Medical Company Information
  45. 8.8.2 Taewoong Medical Business Overview
  46. 8.8.3 Taewoong Medical Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Taewoong Medical Non Vascular Stent Product Portfolio
  48. 8.8.5 Taewoong Medical Recent Developments
  49. 8.9 Merit Medical
  50. 8.9.1 Merit Medical Company Information
  51. 8.9.2 Merit Medical Business Overview
  52. 8.9.3 Merit Medical Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merit Medical Non Vascular Stent Product Portfolio
  54. 8.9.5 Merit Medical Recent Developments
  55. 8.10 ConMed
  56. 8.10.1 ConMed Company Information
  57. 8.10.2 ConMed Business Overview
  58. 8.10.3 ConMed Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ConMed Non Vascular Stent Product Portfolio
  60. 8.10.5 ConMed Recent Developments
  61. 8.11 Applied Medical
  62. 8.11.1 Applied Medical Company Information
  63. 8.11.2 Applied Medical Business Overview
  64. 8.11.3 Applied Medical Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Applied Medical Non Vascular Stent Product Portfolio
  66. 8.11.5 Applied Medical Recent Developments
  67. 8.12 Ella-CS
  68. 8.12.1 Ella-CS Company Information
  69. 8.12.2 Ella-CS Business Overview
  70. 8.12.3 Ella-CS Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ella-CS Non Vascular Stent Product Portfolio
  72. 8.12.5 Ella-CS Recent Developments
  73. 8.13 Garson
  74. 8.13.1 Garson Company Information
  75. 8.13.2 Garson Business Overview
  76. 8.13.3 Garson Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Garson Non Vascular Stent Product Portfolio
  78. 8.13.5 Garson Recent Developments
  79. 8.14 Micro-Tech
  80. 8.14.1 Micro-Tech Company Information
  81. 8.14.2 Micro-Tech Business Overview
  82. 8.14.3 Micro-Tech Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Micro-Tech Non Vascular Stent Product Portfolio
  84. 8.14.5 Micro-Tech Recent Developments
  85. 8.15 S&G Biotech
  86. 8.15.1 S&G Biotech Company Information
  87. 8.15.2 S&G Biotech Business Overview
  88. 8.15.3 S&G Biotech Non Vascular Stent Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 S&G Biotech Non Vascular Stent Product Portfolio
  90. 8.15.5 S&G Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non Vascular Stent Value Chain Analysis
  2. 9.1.1 Non Vascular Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non Vascular Stent Sales Mode & Process
  6. 9.2 Non Vascular Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non Vascular Stent Distributors
  9. 9.2.3 Non Vascular Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst